|

Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA] Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Henan Institute of Cardiovascular Epidemiology1

Indications

  • ST-elevation Myocardial Infarction (STEMI)1
  • Heart Disease1

Other1 trial

Effect of Very Early and Rapid Lowering Cholesterol With Evolocumab on Left Ventricular Remodeling in Patients With Anterior STEMI Undergoing Primary PCI
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.